Skip to content

HP PHARMA

Active Private limited companyfounded 2004active for 22 yearsRue de la Charrette 30, 4130 EsneuxKBO/BCE: BE 0863.578.231

Timeline

33 events since 2004

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBmicro format · 25 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0863578231
Annual accounts 2024 filed PDFmicro format · 21 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 22 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 20 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 18 days before the deadline
Change of role: , from manager to directorPermanent representative: · General meeting of 20-01-20225 points ▸
  • General meeting, 20-01-2022
  • Director resignation, (manager)
  • Director appointment, (director (not named in the articles))
  • Permanent representative, (représentant permanent de la présente société)
  • Registered office clause, rue de la Charrette 30, 4130 Esneux (Tilff)
  • The deed holds 7 more points.

Open the deed in the Belgian Official Gazette

2021
Annual accounts 2020 filed PDFmicro format · 25 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 3 days late
2019
Annual accounts 2018 filed PDFmicro format · on the deadline day
2018
Liquidity more than quadruples current ratio 1.18 The current ratio rises from 0.26 to 1.18. Short-term debt falls from €213,762 to €118,523.
Annual accounts 2017 filed PDFmicro format · 22 days late
Capital decrease of €283,500 to €20,000Capital from €303,500 to €20,000 · General meeting of 17-05-20185 points ▸
  • General meeting, 17-05-2018
  • Capital decrease, €283,500
  • Capital, €20,000, 1,517 shares
  • Amendment of the articles, article 5
  • Power of attorney,
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

2017
Annual accounts 2016 filed PDFmicro format · 22 days late
2016
Annual accounts 2015 filed PDFfull format · 23 days late
2015
Annual accounts 2014 filed PDFfull format · 25 days late
2014
Equity above €500,000 equity €598,561 ▲186% Equity rises from €209,523 to €598,561.
Annual accounts 2013 filed PDFfull format · 6 days before the deadline
2013
Highest result from 2006 to 2025 net €114,942 ▲61.2% The net result of €114,942 is the highest of those years.
Annual accounts 2012 filed PDFfull format · 9 days late
2012
Annual accounts 2011 filed PDFfull format · 43 days late
2011
Annual accounts 2010 filed PDFfull format · 18 days before the deadline
2010
Equity above €200,000 equity €253,556 ▲29.9% With a profit in every financial year since 2006, equity grows to €253,556.
Annual accounts 2009 filed PDFfull format · 18 days before the deadline
2009
Equity above €150,000 equity €195,247 ▲31.2% With a profit in every financial year since 2006, equity grows to €195,247.
Annual accounts 2008 filed PDFfull format · 3 days before the deadline
2008
Annual accounts 2007 filed PDFfull format · 17 days before the deadline
2007
Equity above €100,000 equity €105,958 ▲47.1% With a profit in every financial year since 2006, equity grows to €105,958.
Annual accounts 2006 filed PDFfull format · 21 days before the deadline
2006
Annual accounts 2005 filed PDFfull format
2005
Annual accounts 2004 filed PDFfull format
2004
Incorporation PDFpublished on 02-03-2004
First establishment Rue de la Charrette 30, Esneux

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

HP PHARMA was incorporated on 20 February 2004.1 Total assets fell from €1.1m in 2018 to €778,484 in 2025 and headcount from 1 full-time equivalents in 2022 to 1 in 2024.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018, 2022, 2024 and 2025

Next steps